Document is current
Any future updates will be listed below
-
Authors
Egger, Michael E.
- License Information
-
More Information
Article History
Received: 5 January 2023
Accepted: 23 January 2023
First Online: 3 February 2023
Disclosures
: The author reports instiutional research support from SkylineDX, unrelated to this study, and the author entered into a consultancy agreement with Iovance Biotherapeutics.
Free to read: This content has been made available to all.
